• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

[(pF)Phe4]Nociceptin(1-13)NH2 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5763883

Highly potent and selective nociceptin/orphanin FQ receptor (OP4) agonist peptide (pKi = 10.68; pEC50 = 9.80). Displays > 8000-fold selectivity over delta, kappa, and u opioid receptors and has relatively long lasting pronociceptive, hypotensive, negative… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
[(pF)Phe4]Nociceptin(1-13)NH2, Inhibitor
Full Product Name
[(pF)Phe4]Nociceptin(1-13)NH2
Product Synonym Names
[(pF)Phe4]Nociceptin(1-13)NH2
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
1399.6
Solubility
Water: 2mg/mL
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C61H99FN22O15
CAS Number
380620-88-2

Product References and Citations for [(pF)Phe4]Nociceptin(1-13)NH2, inhibitor

Bigoni et al (2002) Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. In vitro studies. Naunyn Schmiedebergs Arch.Pharmacol. 365 442 PMID:
Bigoni et al (2002) Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies. Naunyn Schmiedebergs Arch.Pharmacol. 365 442 PMID:
Guerrini et al (2001) Structure-activity studies of the Phe4 residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J.Med.Chem. 44 3956 PMID:
Guerrini et al (2001) Structure-activity studies of the Phe4 residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J.Med.Chem. 44 3956 PMID:
Rizzi et al (2002) Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch.Pharmacol. 365 450 PMID:
Rizzi et al (2002) Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch.Pharmacol. 365 450 PMID:

Other Notes

Small volumes of [(pF)Phe4]Nociceptin(1-13)NH2, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for [(pF)Phe4]Nociceptin(1-13)NH2 purchase

MBS5763883 is an inhibitor targeting [(pF)Phe4]Nociceptin(1-13)NH2.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000